Great Job on the quarterly results Steve, though I was wondering if you could shed some light on the patent for a medical device that was with Allergan... Brigitte Phah, Skywork Solutions... Donald Bollella and with Peregrine Pharmaceuticals... Ramon Valencia ?
Great Job on the quarterly results Steve, though one more question I had was if your company has had any talks or collaborations with any Agricultural use with your patents regarding PS Targeting? ... since it is known that Monsanto, Bayer, Koch and other chemical companies/fertilizers destroy cells within plants just as chemo has done and may also need help in restoring the immune system of plants/crops of our food supply.
Great Job on the quarterly results Steve, though one last question... when you changed transfer agents over to Broadridge, how often do you analyze your shareholder base and can you break down percentage-wise and number of the broker non-votes that exist overseas and what would their average holdings be ?
Lets go analysts... be creative today in asking some questions and don't be timid
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
AI
